HomePress and publicationsRandomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF).
Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF).
Cookie Settings
This website uses cookies'. We do this to provide an optimal user experience. Cookies allow us to record and analyze the way the website is used. We want to optimize the website for a better experience.
